TranS1 Inc. (Nasdaq: TSON) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AxiaLIF ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE